The Innovative Medicines Initiative: a Public Private Partnership Model to Foster Drug Discovery

The Innovative Medicines Initiative (IMI) is a large-scale public–private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI aims to boost the development of new medicines across Europe by implementing new collaborative...

Descripción completa

Detalles Bibliográficos
Autor principal: Vaudano, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology (RNCSB) Organization 2013
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962198/
https://www.ncbi.nlm.nih.gov/pubmed/24688725
http://dx.doi.org/10.5936/csbj.201303017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962198/
https://www.ncbi.nlm.nih.gov/pubmed/24688725
http://dx.doi.org/10.5936/csbj.201303017

Ejemplares similares